Ttn as a likely causal gene for QTL of alcohol preference on mouse chromosome 2
- 494 Downloads
KeywordsQuantitative Trait Locus Candidate Gene Muscle Protein Causal Gene Mouse Chromosome
Many quantitative trait loci (QTL) influencing mouse model phenotypes for alcoholism have been mapped genetically. However, the gene(s) comprising the QTL (QTG) are largely unknown. In previous work, Bennett and colleagues created congenic strains carrying the DBA/2IBG (D2) region for alcohol preference (AP) on chromosome 2, on a C57BL/6IBG (B6) background . Subsequently, interval specific congenic recombinant strains (ISCRS), in which the full D2 QTL region was broken into smaller, partially overlapping regions of introgression, were generated and tested. With information from two ISCRS, the QTL has been mapped onto mouse chromosome 2 (Chr2) in a region of 3.4Mb by using C57BL/6J (B6) x DBA/2J (D2) recombinant inbred (RI) strains as well as by using F2 populations. Several candidate genes, Gad1, Atp5g3, Atf2, Sp3 and Sp9, have been evaluated but none of them has been confirmed for a definitive role in the regulation of the QTL of AP on Chr2 [2, 3].
Materials and methods
We have been searching candidate genes for this QTL intensively by using an integrative approach including: 1) bioinformatics tools to search potential functionally relevant genes of alcohol preference within the QTL region ; 2) searching for single nucleotide polymorphisms (SNPs) within the exons of every gene between B6 and D2 in the QTL region; 3) conducting real time PCR to examine the differentially expressed genes between B6 and alcohol preferred interval-specific congenic recombinant strains (ISCRS); and 4) analysis of the association of candidate genes in the human population.
Titin (Ttn) is known as a giant muscle protein expressed in the cardiac and skeletal muscles. However, its expression level in the tongue is known to be higher than that in the heart. We therefore investigated if Ttn plays a role in the regulation of AP. Our data indicated that 1) the expression level of Ttn in the less AP congenic strains is significantly higher than that in B6; 2) the expression of a Ttn probe in the BXD RI strains is negatively correlated to that of AP; 3) One SNP is up- and the other is down-stream of Ttn. The alcohol consumption of the B6 genotype is significantly higher than that of D2 genotype in the BXD RI strains, based on data from multiple reports using two-bottles of choice; and 4) the polymorphism of TTN in the human population is highly associated with alcoholism.
We conclude that Ttn is likely a causal gene for the QTL on Ch2 for the AP.
Research supported by the National Institutes of Health, United States (research grants #AA016342, #DA12849, #DA12690, #AA017535, #AA12870, and #AA11330). Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University (contract number N01-HG-65403). Dr. Kranzler has been a paid consultant for Alkermes, Lilly, Lundbeck, Pfizer, and Roche. He also reports associations with Eli Lilly, Janssen, Schering Plough, Lundbeck, Alkermes, GlaxoSmithKline, Abbott, and Johnson & Johnson, as these companies provide support to the ACNP Alcohol Clinical Trials Initiative (ACTIVE) and Dr. Kranzler has received honoraria from ACTIVE. The other authors report no financial interests or potential conflicts of interest.
- 1.Bennett B, Beeson M, Gordon L, Carosone-Link P, Johnson TE: Genetic dissection of quantitative trait loci specifying sedative/hypnotic sensitivity to ethanol: mapping with interval-specific congenic recombinant lines. Alcohol Clin Exp Res. 2002, 26 (11): 1615-1624. 10.1111/j.1530-0277.2002.tb02463.x.CrossRefPubMedGoogle Scholar
- 2.Wang LS, Jiao Y, Huang Y, Liu XY, Gibson G, Bennett B, Hamre KM, Li DW, Zhao HY, Gelernter J, Kranzler HR, Farrer LA, Lu L, Wang YJ, Gu WK: Critical evaluation of transcription factor Atf2 as a candidate modulator of alcohol preference in mouse and human populations. Genet Mol Res. 2013, 12 (4): 5992-6005. 10.4238/2013.November.26.9.PubMedCentralCrossRefPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.